Serum endocan as a survival predictor for patients with liver cirrhosis

about

ESM-1 siRNA Knockdown Decreased Migration and Expression of CXCL3 in Prostate Cancer Cells.P-selectin, endocan, and some adhesion molecules in obese children and adolescents with non-alcoholic fatty liver disease.Serum endocan levels in patients with stable COPD

P2860

Q42283730-35CE163B-7546-4C72-B350-094851519965 Q51093923-13D1E9A9-5441-4E9A-A4F9-3EE7AB590AE4 Q58563180-05F8AF93-6AC0-4508-BA9B-9D24ABEEF303

P2860

Serum endocan as a survival predictor for patients with liver cirrhosis

Item

http://www.wikidata.org/entity/Q36425719

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Serum endocan as a survival predictor for patients with liver cirrhosis

@ast

Serum endocan as a survival predictor for patients with liver cirrhosis

@en

type

Item

label

Serum endocan as a survival predictor for patients with liver cirrhosis

@ast

Serum endocan as a survival predictor for patients with liver cirrhosis

@en

prefLabel

Serum endocan as a survival predictor for patients with liver cirrhosis

@ast

Serum endocan as a survival predictor for patients with liver cirrhosis

@en

P1476

Serum endocan as a survival predictor for patients with liver cirrhosis

@en

P2093

Kazuaki Ozaki

http://www.w3.org/2001/XMLSchema#string

Mikihiro Tsutsumi

http://www.w3.org/2001/XMLSchema#string

Nobuyuki Toshikuni

http://www.w3.org/2001/XMLSchema#string

P2860

ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines.

Endocan expression and relationship with survival in human non-small cell lung cancer.

Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy.

Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan.

Transcriptional repression of the transforming growth factor β (TGF-β) Pseudoreceptor BMP and activin membrane-bound inhibitor (BAMBI) by Nuclear Factor κB (NF-κB) p50 enhances TGF-β signaling in hepatic stellate cells.

Serum endocan as a novel prognostic biomarker in patients with hepatocellular carcinoma.

Clinicopathological correlation of endocan expression and survival in epithelial ovarian cancer.

Ascorbic acid suppresses endotoxemia and NF-κB signaling cascade in alcoholic liver fibrosis in guinea pigs: a mechanistic approach.

Endocan expression correlated with poor survival in human hepatocellular carcinoma.

Serum proteoglycans as prognostic biomarkers of hepatocellular carcinoma in patients with alcoholic cirrhosis.

P304

427-430

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/153805

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Joseph George

P577

2015-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

287202602

http://www.w3.org/2001/XMLSchema#string

P698

26669300

http://www.w3.org/2001/XMLSchema#string

P932

4699609

http://www.w3.org/2001/XMLSchema#string

Serum endocan as a survival predictor for patients with liver cirrhosis

about

P2860

P2860

Serum endocan as a survival predictor for patients with liver cirrhosis

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932